Applications Sought for New Funding Announcement!

Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases          Visit us on the Web The NIAID Radiation/Nuclear Countermeasures Program (RNCP) supports extramural research to develop safe and effective radiation medical countermeasures and biodosimetry methods and/or devices for clinical use under emergency situations. Applications are being sought for the following: Centers for Medical Countermeasures Against Radiation Consortium (U19 Clinical Trial Not Allowed) (Funding Opportunity Announcement Number: RFA-AI-19-012): The goals of this FOA follow: Develop new techniques and devices to measure radiation exposure in the human body Follow biomarkers of tissue damage and recovery Further develop existing (e.g. products in clinical use) as well as novel therapies to minimize tissue damage, hasten tissue recovery, restore normal physiological function, and improve survival Applications are due May 31, 2019. See the funding opportunity announcement for RFA-AI-19-012. Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107